1. Home
  2. INO vs AGPU Comparison

INO vs AGPU Comparison

Compare INO & AGPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.10

Market Cap

90.5M

Sector

Health Care

ML Signal

HOLD

Logo Axe Compute Inc. Common Stock

AGPU

Axe Compute Inc. Common Stock

N/A

Current Price

$7.58

Market Cap

77.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
INO
AGPU
Founded
1979
2002
Country
United States
United States
Employees
N/A
14
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.5M
77.0M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
INO
AGPU
Price
$1.10
$7.58
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$6.75
N/A
AVG Volume (30 Days)
1.5M
271.2K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
54.18
N/A
EPS
N/A
N/A
Revenue
$42,220,086.00
N/A
Revenue This Year
$20,156.19
$12,476.23
Revenue Next Year
$421.95
$55.17
P/E Ratio
N/A
N/A
Revenue Growth
19.37
N/A
52 Week Low
$1.03
$1.03
52 Week High
$2.86
$10.86

Technical Indicators

Market Signals
Indicator
INO
AGPU
Relative Strength Index (RSI) 43.35 57.89
Support Level $1.03 $4.54
Resistance Level $1.23 $8.81
Average True Range (ATR) 0.05 0.74
MACD 0.01 -0.02
Stochastic Oscillator 45.00 84.76

Price Performance

Historical Comparison
INO
AGPU

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

About AGPU Axe Compute Inc. Common Stock

Axe Compute Inc functions as an active infrastructure operator. The company intends to expand access to AI compute resources by utilizing the Aethir network, which provides scalable, cost-efficient cloud GPU services for AI, machine learning, gaming, and rendering applications. Through the use of Aethir's decentralized international infrastructure, the company aims to provide access to bare-metal GPUs at scale for both emerging and established organizations.

Share on Social Networks: